Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a 13.022\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCN(C(=O)CN1C(=O)NC2(CCc3ccccc32)C1=O)C1CCS(=O)(=O)C1
[b] Cc1c(Cl)cnc(NC(=O)COC(=O)c2ccc3ncsc3c2)c1Cl
[c] O/N=C/c1c(OCc2ccc(Cl)cc2)ccc2ccccc12
Answer: a. CCN(C(=O)CN1C(=O)NC2(CCc3ccccc32)C1=O)C1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)CN1C(=O)NC2(CCc3ccccc32)C1=O)C1CCS(=O)(=O)C1
CCN(C(=O)CN1C(=O)NC2(CCc3ccccc32)C1=O)C1CCS(=O)(=O)C1
2-(2',5'-dioxospiro[1,2-dihydroindene-3,4'-imidazolidine]-1'-yl)-N-(1,1-dioxothiolan-3-yl)-N-ethylacetamide